This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04928846
Brief Title: A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

First Submitted : June 14, 2021
First Submitted that Met QC Criteria : June 14, 2021
First Posted : June 16, 2021

Last Update Submitted that Met QC Criteria : April 9, 2024
Last Update Posted : April 11, 2024